Medical Students Articles

Med Student

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Olliaro P et al. - The available treatments for VL are cost-effective, and the mortality and incidence-based methods produce consistent estimates. The combinations considered here were more cost-effective than most monotherapies. Having multiple treatment options and combining drugs are also likely to reduce drug pressure and prolong the drugs' life-span of effective use.

Related Articles

Cutaneous leishmaniasis treated with itraconazole
Dermatologic Therapy, 11/20/09    Relevance Score: 85%

Cutaneous and mucocutaneous leishmaniasis
Dermatologic Therapy, 11/20/09    Relevance Score: 85%

Determinants of bednet ownership and use in visceral leishmaniasis-endemic areas of the Indian subcontinent
Tropical Medicine & International Health, 11/17/09    Relevance Score: 84%

Diffuse (anergic) cutaneous leishmaniasis responding to amphotericin B
Clinical and Experimental Dermatology, 11/17/09    Relevance Score: 84%

The Antituberculosis Drug Pyrazinamide Affects the Course of Cutaneous Leishmaniasis In Vivo and Increases Activation of Macrophages and Dendritic Cells
Antimicrobial Agents and Chemotherapy, 11/20/09    Relevance Score: 83%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address